Invesco Ltd. (IVZ) P/E Ratio History
Historical price-to-earnings valuation from 2000 to 2025
Loading P/E history...
IVZ Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Invesco Ltd. (IVZ) trades at a price-to-earnings ratio of -17.1x, with a stock price of $27.35 and trailing twelve-month earnings per share of $-0.54.
The current P/E is 247% below its 5-year average of 11.7x. Over the past five years, IVZ's P/E has ranged from a low of 6.8x to a high of 17.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.4x, IVZ trades at a 228% discount to its sector peers. The sector includes 774 companies with P/E ratios ranging from 0.0x to 195.8x.
Relative to the broader market, IVZ trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our IVZ DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
IVZ P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $16B | 34.2 | - | +7% | |
| $23B | 11.5 | - | +1% | |
| $8B | 13.5 | 0.34Best | +50%Best | |
| $960M | 7.2Lowest | 0.49 | +18% | |
| $473M | 9.8 | 1.18 | +14% | |
| $167B | 25.6 | 3.15 | +15% | |
| $43B | 18.4 | 2.09 | +47% | |
| $3B | 9.3 | 2.62 | +11% | |
| $6B | 18.9 | 1.66 | +3% | |
| $164B | 30.8 | 13.46 | +18% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
IVZ Historical P/E Data (2000–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $22.94 | $1.47 | 15.6x | -9% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $15.77 | $0.93 | 17.0x | -1% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $15.17 | $1.25 | 12.1x | -29% |
| FY2024 Q4 | $17.48 | $1.18 | 14.8x | -14% | |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $14.52 | $1.31 | 11.1x | -35% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $16.81 | $1.41 | 11.9x | -30% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $16.40 | $1.38 | 11.9x | -31% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $17.99 | $1.49 | 12.1x | -30% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $13.70 | $2.00 | 6.8x | -60% |
| FY2022 Q2 | $16.13 | $2.32 | 7.0x | -59% | |
| FY2022 Q1 | $23.06 | $2.85 | 8.1x | -53% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $23.02 | $3.00 | 7.7x | -55% |
Average P/E for displayed period: 17.2x
Full IVZ Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See IVZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IVZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IVZ vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonIVZ — Frequently Asked Questions
Quick answers to the most common questions about buying IVZ stock.
Is IVZ stock overvalued or undervalued?
IVZ trades at -17.1x P/E, below its 5-year average of 11.7x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does IVZ's valuation compare to peers?
Invesco Ltd. P/E of -17.1x compares to sector median of 13.4x. The discount suggests lower growth expectations or higher risk.
What is IVZ's PEG ratio?
IVZ PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2000-2025.